3-Bromopyruvic Acid Inhibits Tricarboxylic Acid Cycle and Glutaminolysis in HepG2 Cells.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Anticancer Research

• Publication date

  2016-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  PMID 27127128
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti-cancer drugs targeting fatty acid synthase (FAS).

  2012cited by this paper
• MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors

  2012cited by this paper
• Comparative Metabolic Flux Profiling of Melanoma Cell Lines

  2011cited by this paper
• Otto Warburg's contributions to current concepts of cancer metabolism

  2011cited by this paper
• Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability

  2011cited by this paper
• Glutamine: pleiotropic roles in tumor growth and stress resistance

  2011cited by this paper
• Anticancer Drugs Targeting the Mitochondrial Electron Transport Chain

  2011cited by this paper
• Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia

  2011cited by this paper
• Reductive carboxylation supports growth in tumor cells with defective mitochondria

  2011cited by this paper
• A simple method for measuring intracellular activities of glutamine synthetase and glutaminase in glial cells.

  2011cited by this paper
• Respiratory competent mitochondria in human ovarian and peritoneal cancer.

  2011cited by this paper
• Rapid determination of tricarboxylic acid cycle enzyme activities in biological samples

  2010cited by this paper
• Glutamine addiction: a new therapeutic target in cancer.

  2010cited by this paper
• Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells.

  2010cited by this paper
• Mitochondrial Targeting of Vitamin E Succinate Enhances Its Pro-apoptotic and Anti-cancer Activity via Mitochondrial Complex II*

  2010cited by this paper
• Targeting metabolic transformation for cancer therapy

  2010cited by this paper
• Glutaminase: A Hot Spot For Regulation Of Cancer Cell Metabolism?

  2010cited by this paper
• Quantifying the global cellular thiol–disulfide status

  2009cited by this paper
• Targets of 3-bromopyruvate, a new, energy depleting, anticancer agent.

  2009cited by this paper
• Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells

  2009cited by this paper
• Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is pyruvylated during 3-bromopyruvate mediated cancer cell death.

  2009cited by this paper
• Cancer cell metabolism: Warburg and beyond.

  2008cited by this paper
• Synergistic Antipancreatic Tumor Effect by Simultaneously Targeting Hypoxic Cancer Cells With HSP90 Inhibitor and Glycolysis Inhibitor

  2008cited by this paper
• Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species

  2007cited by this paper
• Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma

  2007cited by this paper
• Organelle isolation: functional mitochondria from mouse liver, muscle and cultured filroblasts

  2007cited by this paper
• Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance.

  2006cited by this paper
• Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer

  2006cited by this paper
• Inactivation of H+-vacuolar ATPase by the energy blocker 3-bromopyruvate, a new antitumour agent.

  2006cited by this paper
• HIF, a missing link between metabolism and cancer

  2005cited by this paper
• Glucose Metabolism Heterogeneity in Human and Mouse Malignant Glioma Cell Lines

  2005cited by this paper
• Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia.

  2005cited by this paper
• The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid β-oxidation

  2005cited by this paper
• Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP.

  2004cited by this paper
• Mitochondrial Bound Hexokinase Activity as a Preventive Antioxidant Defense

  2004cited by this paper
• Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase.

  2001cited by this paper
• Involvement of alpha-cysteine-62 and beta-tryptophan-135 in human pyruvate dehydrogenase catalysis.

  1999cited by this paper
• Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor.

  1997cited by this paper
• Kinetics of inactivation of bovine pancreatic ribonuclease A by bromopyruvic acid.

  1996cited by this paper
• Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation.

  1992cited by this paper
• Determination of pyruvate dehydrogenase and acetyl-CoA synthetase activities using citrate synthase.

  1981cited by this paper
• The inactivation of succinate dehydrogenase by bromopyruvate.

  1971cited by this paper
• Regulation of D-fructose 1-phosphate kinase by potassium ion.

  1970cited by this paper
• Effects of bromopyruvate on the control and catalytic properties of glutamate dehydrogenase.

  1969cited by this paper
• On the origin of cancer cells.

  1956cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Comparison of popular enrichment methods for untargeted in vitro metabolomics

  2025cites this paper
• Glucose Metabolism as a Potential Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia

  2024cites this paper
• TCA cycle impairment leads to PIN2 internalization and degradation via reduced MAB4 level and ARA6 components in Arabidopsis roots

  2024cites this paper
• Metabolic profiling and combined therapeutic strategies unveil the cytotoxic potential of selenium-chrysin (SeChry) in NSCLC cells

  2024cites this paper
• Stimuli-responsive cancer nanomedicines inhibit glycolysis and impair redox homeostasis.

  2023cites this paper
• Targeting Glucose Metabolism in Cancer Cells as an Approach to Overcoming Drug Resistance

  2023cites this paper
• Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis

  2023cites this paper
• 3-Bromopyruvate inhibits the growth and glucose metabolism of TNBC xenografts in nude mice by targeting c-Myc.

  2023cites this paper
• Strigol1/albumin/chitosan nanoparticles decrease cell viability, induce apoptosis and alter metabolomics profile in HepG2 cancer cell line.

  2021cites this paper
• 3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation

  2021influential citation
• Mitochondrial Function Are Disturbed in the Presence of the Anticancer Drug, 3-Bromopyruvate

  2021cites this paper
• The Anticancer Drug 3-Bromopyruvate Induces DNA Damage Potentially Through Reactive Oxygen Species in Yeast and in Human Cancer Cells

  2020cites this paper
• 3-Bromopyruvate Regulates the Status of Glycolysis and BCNU Sensitivity in Human Hepatocellular Carcinoma Cells.

  2020cites this paper
• Progression-Dependent Altered Metabolism in Osteosarcoma Resulting in Different Nutrient Source Dependencies

  2020cites this paper
• Can a metabolism-targeted therapeutic intervention successfully subjugate SARS-COV-2? A scientific rational

  2020cites this paper
• Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment

  2019influential citation
• The progress and development of GLUT1 inhibitors targeting cancer energy metabolism.

  2019cites this paper
• Diverse Stakeholders of Tumor Metabolism: An Appraisal of the Emerging Approach of Multifaceted Metabolic Targeting by 3-Bromopyruvate

  2019cites this paper
• Targeting energy metabolism to eliminate cancer cells

  2018cites this paper
• Mitocans: Mitochondrially Targeted Anti-cancer Drugs

  2018cites this paper
• B Vitamins Can Reduce Body Weight Gain by Increasing Metabolism-related Enzyme Activities in Rats Fed on a High-Fat Diet

  2018cites this paper
• Antitumor action of 3‐bromopyruvate implicates reorganized tumor growth regulatory components of tumor milieu, cell cycle arrest and induction of mitochondria‐dependent tumor cell death

  2018cites this paper
• Monocarboxylate transporter 1 (MCT1), a tool to stratify acute myeloid leukemia (AML) patients and a vehicle to kill cancer cells

  2017cites this paper
• A perillyl alcohol-conjugated analog of 3-bromopyruvate without cellular uptake dependency on monocarboxylate transporter 1 and with activity in 3-BP-resistant tumor cells.

  2017cites this paper
• Antitumor and chemosensitizing action of 3-bromopyruvate: Implication of deregulated metabolism.

  2017cites this paper
• Lineage-Specific Metabolic Properties and Vulnerabilities of T Cells in the Demyelinating Central Nervous System

  2017cites this paper
• On mitochondrial metabolism in tumor biology

  2017cites this paper
• Molecular docking studies of 3-bromopyruvate and its derivatives to metabolic regulatory enzymes: Implication in designing of novel anticancer therapeutic strategies

  2017cites this paper
• The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside

  2016cites this paper
• A medical understanding on the wuxing theory in cell

  2016cites this paper